Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment

American Journal of Pathology

Volumn 173, Issue 5, 2008, Pages 1528-1539

  McCawley, Lisa J ^a   Wright, Jane ^a   LaFleur, Bonnie J ^b,c   Crawford, Howard C ^a,d   Matrisian, Lynn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CARCINOGENICITY; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; IN VITRO STUDY; KERATINOCYTE; LEUKOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SKIN BIOPSY; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 55349131011     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080132     Document Type: Article

References (59)

1. Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4:617-629
2. Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002, 3:207-214
3. McCawley LJ, Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001, 13:534-540
4. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174
5. Page-McCaw A, Ewald AJ, Werb Z: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233
6. Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392
7. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70
8. Martin MD, Matrisian LM: The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007, 26:717-724
9. Lopez-Otin C, Matrisian LM: Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007, 7:800-808
10. Radisky D, Hagios C, Bissell MJ: Tumors are unique organs defined by abnormal signaling and context. Semin Cancer Biol 2001, 11:87-95
11. Overall CM, Kleifeld O: Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006, 6:227-239
12. Hu J, Van den Steen PE, Sang QX, Opdenakker G: Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 2007, 6:480-498
13. Madlener M, Parks WC, Werner S: Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998, 242:201-210
14. Saarialho-Kere UK, Vaalamo M, Airola K, Niemi KM, Oikarinen AI, Parks WC: Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin diseases. J Invest Dermatol 1995, 104:982-988
15. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994, 94:79-88
16. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT: Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996, 106:1119-1124
17. Kerkela E, Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 2003, 12:109-125
18. Nagase H: Stromelysins 1 and 2. Matrix metalloproteinases. Edited by WC Parks and RP Mecham. San Diego, Academic Press, 1998, pp. 43-84
19. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma: a clinicopathologic study. Cancer 1992, 70:2747-2753
20. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T: Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 1995, 53:530-534
21. Airola K, Johansson N, Kariniemi AL, Kahari VM, Saarialhokere UK: Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997, 109:225-231
22. Kerkela E, Ala-aho R, Lohi J, Grenman R, Kahari V, Saarialho-Kere U: Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 2001, 84:659-669
23. Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P: Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 1991, 11:76-83
24. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ: Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997, 139:1861-1872
25. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127
26. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z: The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146
27. McCawley LJ, Crawford HC, King LE, Jr., Mudgett J, Matrisian LM: A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 2004, 64:6965-6972
28. Abramson SR, Conner GE, Nagase H, Neuhaus I, Woessner JF: Jr.: Characterization of rat uterine matrilysin and its cDNA Relationship to human pump-1 and activation of procollagenases. J Biol Chem 1995, 270:16016-16022
29. Blessing M, Nanney LB, King LE, Jones CM, Hogan BL: Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev 1993, 7:204-215
30. Park AJ, Matrisian LM, Kells AF, Pearson R, Yuan Z, Navre M: Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch." J Biol Chem 1991, 266:1584-1590
31. Witty JP, Wright J, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995, 6:1287-1303
32. Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM: A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 1994, 10:207-215
33. Strickland JE, Greenhalgh DA, Koceva-Chylan A, Hennings H, Resterpo C, Balaschak M, Yuspa SH: Development of murine epidermal cell lines which contain an activated ras Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 1988, 48:165-169
34. McDonnell S, Matrisian LM: Stromelysin in tumor progression and invasion. Cancer Metastasis Rev 1991, 9:305-319
35. Li ER, Owens DM, Djian P, Watt FM: Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp Dermatol 2000, 9:431-438
36. Prentice RL, Williams BJ, Peterson AV: On the Regression-Analysis of Multivariate Failure Time Data. Biometrika 1981, 68:373-379
37. Witty JP, Lempka T, Coffey RJ, Jr., Matrisian LM: Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 1995, 55:1401-1406
38. Ramirez A, Bravo A, Jorcano JL, Vidal M: Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994, 58:53-64
39. Ramirez A, Vidal M, Bravo A, Jorcano JL: Analysis of sequences controlling tissue-specific and hyperproliferation-related keratin 6 gene expression in transgenic mice. DNA Cell Biol 1998, 17:177-185
40. Ramirez A, Vidal M, Bravo A, Larcher F, Jorcano JL: A 5′-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice. Proc Natl Acad Sci USA 1995, 92:4783-4787
41. Haro H, Crawford HC, Fingleton B, MacDougall JR, Shinomiya K, Spengler DM, Matrisian LM: Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 2000, 105:133-141
42. Warner RL, Beltran L, Younkin EM, Lewis CS, Weiss SJ, Varani J, Johnson KJ: Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol 2001, 24:537-544
43. Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG: Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci USA 1999, 96:6885-6889
44. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML: Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005, 169:681-691
45. Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJC: The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991, 302:157-162
46. Bissell MJ, Rizki A, Mian IS: Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003, 15:753-762
47. Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003, 107:1-10
48. Glick AB, Yuspa SH: Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol 2005, 15:75-83
49. Cauwe B, Van den Steen PE, Opdenakker G: The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007, 42:113-185
50. Alexander CM, Howard EW, Bissell MJ, Werb Z: Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinase-1 transgene. J Cell Biol 1996, 135:1669-1667
51. Watt FM: Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002, 21:3919-3926
52. Fuchs E, Raghavan S: Getting under the skin of epidermal morphogenesis. Nat Rev Genet 2002, 3:199-209
53. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693
54. Alexander CM, Selvarajan S, Mudgett J, Werb Z: Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 2001, 152:693-703
55. Pilcher BK, Wang M, Qin XJ, Parks WC, Senior RM, Welgus HG: Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann NY Acad Sci 1999, 878:12-24
56. Page-McCaw A, Ewald AJ, Werb Z: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233
57. D'Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, Conney AH, Chada K: Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 1995, 15:5732-5739
58. Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490
59. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C: Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003, 35:252-257